Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study

New-onset diabetes after androgen-deprivation therapy for prostate cancer: A nationwide propensity score-matched four-year longitudinal cohort study

(2018) Jhen-Hao Jhan et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Type 2 Diabetes and Testosterone Therapy

(2018) Geoffrey Hackett   World Journal of Mens Health

Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man

(2016) Jonathan M. Hazlehurst et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metabolic dysfunction in female mice with disruption of 5α-reductase 1

(2016) Dawn E W Livingstone et al.   JOURNAL OF ENDOCRINOLOGY

Comparative risk of oral ulcerations among antipsychotics users - population-based retrospective cohort study

(2015) Edward Chia-Cheng Lai et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

5-alpha-reductase inhibitors and the risk of diabetes mellitus: A nationwide population-based study

(2015) Shang-Sen Lee et al.   PROSTATE

5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents

(2014) Dawn E.W. Livingstone et al.   DIABETES

5α-Reductase Type 1 Modulates Insulin Sensitivity in Men

(2014) Rita Upreti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Personalized Medicine for the Management of Benign Prostatic Hyperplasia

(2014) Seth K. Bechis et al.   JOURNAL OF UROLOGY

Loss of 5α-Reductase Type 1 Accelerates the Development of Hepatic Steatosis but Protects Against Hepatocellular Carcinoma in Male Mice

(2013) Joanna K. Dowman et al.   ENDOCRINOLOGY

Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride

(2013) Y. K. Loke et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Geographic variation in the age- and gender-specific prevalence and incidence of epilepsy: Analysis of Taiwanese National Health Insurance-based data

(2011) Chih-Chuan Chen et al.   EPILEPSIA

Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

(2011) David Preiss   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Histamine2-Receptor Antagonists Are an Alternative to Proton Pump Inhibitor in Patients Receiving Clopidogrel

(2010) Chun–Ying Wu et al.   GASTROENTEROLOGY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Effect of Dutasteride on the Risk of Prostate Cancer

(2010) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validation of the national health insurance research database with ischemic stroke cases in Taiwan

(2010) Ching-Lan Cheng et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

(2009) Emily Herrett et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Diabetes in Asia

(2009) Juliana C. N. Chan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION